جست‌وجوی استاد و پژوهشگر

Amir A. Sadighi Akhaمشاهده پروفایل

پژوهشگر

• Immunology
• Clinical Immunology
• Autoimmune Disorders
• +۴ مورد دیگر

Amir A. Sadighi Akha, M.D., Ph.D., is a faculty member at the Mayo Clinic Department of Laboratory Medicine and Pathology. He holds a D.Phil in Immunology from the University of Oxford and an M.D. from the University of Tehran School of Medicine, with postdoctoral training in immunopathology at Johns Hopkins University School of Medicine. Education 1999: Fellow, Immunopathology & Pediatric Immunology, Johns Hopkins University 1996: D.Phil in Immunology, University of Oxford 1991: M.D., University of Tehran His research focuses on immunological mechanisms in aging, autoimmune disorders, and clinical cytometry for immunodeficiencies. Recent work includes: Development of diagnostic frameworks for primary immunodeficiencies Investigation of genetic variants in immune dysregulation Multiomics modeling for predictive biomarkers in infectious diseases Studies on cytokine signaling and mucosal immunity in mouse models Notable scientific awards include the 1991 Iranian Presidential Certificate of Appreciation for top graduate status and the 2004 Keble College Senior Common Room appointment. Professional Memberships Clinical Immunology Society (2025–present) Federation of Clinical Immunology Societies (2024–present) Association of Medical Laboratory Immunologists (2023–present) He contributes to Mayo Clinic's Centers of Excellence and pediatric clinical programs, with expertise in flow cytometry and anti-cytokine autoantibody analysis.

Karl-Johan Malmbergمشاهده پروفایل

استاد

• Natural Killer Cell Biology
• Cancer Immunotherapy
• Precision Immunology
• +۴ مورد دیگر

Karl-Johan Malmberg is a Professor at the University of Oslo , affiliated with the Faculty of Medicine and leading research at the Radiumhospitalet . His work focuses on Natural Killer (NK) cell biology and precision immunotherapy , with a strong emphasis on cancer immunology , HLA-KIR interactions , and cell therapy engineering . He collaborates extensively with the PRIMA - Precision Immunotherapy Alliance and contributes to translational research in hematopoietic stem cell transplantation and solid tumor immunotherapy . Expert in NK cell education and functional reprogramming Develops allogeneic cell therapies for leukemia and multiple myeloma Pioneers single-cell and high-dimensional analysis of immune compartments Recent publications highlight innovations in NK cell migration inhibition via GPR56, NKG2A/C switch receptors , and nanoparticle-enhanced NK cell activation . His team drives computational tools like MetaGate for cytometry data integration. Key affiliations include the Research Council of Norway Center of Excellence (PRIMA) , with a focus on cell therapy translation and tumor immune microenvironment mapping .

Uwe Roehmمشاهده پروفایل

دانشیار

• Distributed Data Management on Modern Hardware
• Integrated Machine Learning with Databases
• Interactive Big Data Analytics
• +۵ مورد دیگر

Associate Professor Uwe Roehm is a faculty member at the University of Sydney's School of Computer Science, specializing in database systems and big data analytics. He holds a PhD from ETH Zurich and joined the University of Sydney in 2004. His research focuses on distributed data management, integrating machine learning with databases, and scalable data processing for bioinformatics. Education: PhD in Computer Science, ETH Zurich (2002) Diplom-Informatics (MSc equivalent), University of Passau Research Interests: Database Systems and Transaction Processing Human-Centred Data Management Freshness-Aware Scheduling (FAS) Big Data Analytics and Cloud Computing Key Projects and Contributions: Developed Serialisable Snapshot Isolation (SSI), implemented in PostgreSQL Created the Master of Data Science program at the University of Sydney Recipient of the 2018 ACM SIGMOD Test of Time Award Awards: 2018 ACM SIGMOD Test of Time Award 2013 Dean's Award for Outstanding Teaching 2008 ACM SIGMOD Best Paper Award Teaching and Grants: Teaches courses on database systems, data science platforms, and cloud computing Principal Investigator on ARC-funded projects, including Linkage and Discovery grants Labs and Teams: Leads the Database Research Group and contributes to the Human-Centred Technology Research Cluster at the University of Sydney.

Anto Sam Crosslee Louis Sam Titusمشاهده پروفایل

استادیار

• Biomedical Engineering
• Proteomics
• Molecular Biology
• +۵ مورد دیگر

Anto Sam Crosslee Louis Sam Titus is an Assistant Professor in the Department of Biomedical Engineering at the University of Houston. Their research focuses on biomarker discovery, molecular mechanisms of diseases (e.g., lupus nephritis, breast cancer), and advanced diagnostic technologies using imaging mass cytometry, proteomics, and microfluidic devices. They also explore neurodegenerative diseases and epigenetic regulation of genes like Bdnf and MeCP2. Key research areas include: Biomarker development in kidney disease and cancer Machine learning applications in medical diagnostics Multiphoton lithography for flexible bioelectronics Neurological disorders and gene expression modulation Publications span 2017–2024, emphasizing translational research at the intersection of engineering and medicine. While no awards are explicitly listed, their work demonstrates impactful contributions to neuropsychiatric lupus, bladder cancer diagnostics, and HDAC3-mediated gene repression. Advising and grant details are not provided in the text, but their lab focuses on interdisciplinary biomedical engineering challenges.

Viktoria Weberمشاهده پروفایل

استاد

• Biomedical Engineering
• Immunology
• Hematology
• +۴ مورد دیگر

Univ.-Prof. Dr. Viktoria Weber serves as Vice-Rector for Research and Sustainable Development at the University for Continuing Education Krems, Austria. Her work bridges academic leadership and cutting-edge biomedical research, with a focus on biomaterials, extracellular vesicles, and immunothrombosis. Research interests include blood-biomaterial interactions, heparin pharmacology, and the role of extracellular vesicles in disease pathogenesis. She leads studies on stem cell-derived vesicles for regenerative medicine and diagnostic applications. Her lab investigates mechanisms underlying immunothrombosis in sepsis and新冠肺炎. Publications emphasize translational research in biomaterial design, coagulation pathways, and cell signaling. Her work integrates advanced bioreactor systems, flow cytometry standardization, and clinical diagnostics. Current projects explore therapeutic apheresis materials and novel endotoxin detection methods. Her interdisciplinary approach spans bioengineering, immunology, and clinical practice, contributing to innovations in dialysis membranes and blood product safety. She collaborates internationally on MISEV2023 guidelines for extracellular vesicle research standardization.

• Ecological Modeling
• Microbial Ecology
• Flow Cytometry Analysis
• +۳ مورد دیگر

Oluwafemi Olusoji is a researcher affiliated with the Faculty of Sciences at Hasselt University, where he holds a Doctorate in Sciences. His work contributes to the UN Sustainable Development Goals, particularly in areas related to biodiversity and environmental sustainability. He has collaborated on projects focusing on intraspecific biodiversity and experimental design. His research expertise includes ecological modeling, microbial ecology, and flow cytometry analysis. Notable contributions include developing the 'cyanoFilter' R package for phytoplankton population identification and studies on trait diversity in cyanobacteria. His projects often involve interdisciplinary collaboration, such as the co-financed project with UHasselt. Olusoji has published two peer-reviewed articles (2021, 2023), demonstrating his focus on methodological advancements in ecological research. While no explicit awards are listed, his work reflects impactful contributions to environmental science through innovative analytical tools and biodiversity assessments. His doctoral thesis (2023) investigated temperature effects on cyanobacterial diversity, supervised by Prof. De Laender. Research collaborations span Belgium and other institutions, reflecting a global network in ecological studies.

• Applied Machine Learning
• Microbiology
• Drinking Water Distribution Systems
• +۳ مورد دیگر

Niklas Gador is a Senior Lecturer in the Department of Computer Science at the Faculty of Natural Science. His research focuses on applying machine learning techniques to microbiological challenges, particularly in water distribution systems. He specializes in visualization, classification, anomaly detection, forecasting, and reinforcement learning, using Python as his primary tool. Current teaching responsibilities include courses in Discrete Mathematics, Statistics, Methods for Measuring Electricity, and Calculus and Algebra. Research collaborations include projects like EIVF-AI (Enhancing In Vitro Fertilization with AI) and studies on bacterial changes in drinking water systems post-monochloramine removal. He has participated in conferences such as the 3rd Annual RECS Workshop on AI and organized events on smart AI taxi systems. His work frequently involves flow cytometry and environmental data analysis. He serves as a deputy supervisor for a PhD project on bathing water quality using machine learning and DNA-based methods. Despite his active research profile, no scientific awards are explicitly mentioned in the provided texts.

Grégory Battمشاهده پروفایل

پژوهشگر

• Systems biology
• Synthetic biology
• Quantitative modeling
• +۱۵ مورد دیگر

Grégory Batt is a Researcher and Head of the InBio joint research group at the Institut Pasteur and Inria Paris. The lab operates at the intersection of wet and dry biology, focusing on systems and synthetic biology with an emphasis on automation, modeling, and real-time control of cellular processes. The team is affiliated with both institutions and hosts a multidisciplinary group of researchers, engineers, and students. The research interests of Grégory Batt span systems biology, synthetic biology, quantitative modeling, lab automation, bioproduction, and single-cell analysis . His work integrates computational and experimental approaches to develop frameworks for understanding and controlling cellular behavior. Key methodologies include the use of synthetic biology, microfluidics, optogenetics, and robotics. The lab has developed innovative software tools such as ReacSight and MicroMator to enable automated and reactive experimentation. Recent publications highlight trends in real-time control of bioproduction, optimization of protein secretion, parameter inference in stochastic models, and ecological frameworks for antibiotic resistance . These works demonstrate a strong focus on integrating modeling with high-throughput experimentation to solve problems in biotechnology and medicine. Scientific contributions include: Development of ReacSight for bioreactor automation and reactive control Creation of MicroMator for reactive microscopy Application of ecological concepts to bacterial antibiotic responses Modeling stochastic kinetics coupled with auxiliary processes Batt advises several PhD students and postdoctoral researchers, including Henri Galez, Alicia Da Silva, Cecilia Capela, and Viktoriia Gross. His lab has received support from ANR, Inria, and other funding bodies. The InBio team operates a state-of-the-art laboratory equipped with bioreactors, liquid handling robots, flow cytometers, automated microscopes, and high-performance computing resources, enabling advanced research at both population and single-cell levels. The lab, located at the Yersin and Lwoff buildings of the Institut Pasteur in Paris, fosters a collaborative environment integrating molecular biology, microbiology, and computational modeling to advance quantitative understanding of cellular systems.

Javier Cabreraمشاهده پروفایل

استاد

• Biostatistics
• Data Mining
• Clinical Trial Methodology
• +۵ مورد دیگر

Javier Cabrera is a Professor in the Department of Statistics at Rutgers University with a joint affiliation at the Cardiovascular Institute. He holds a Ph.D. from Princeton University and is recognized as a Fulbright Scholar. His office is located at Hill Center 471, 110 Frelinghuysen Road, Piscataway, NJ. His research focuses on: Biostatistics and clinical trial methodology Data mining for functional genomics and DNA/protein arrays Statistical computing, machine vision, and high-dimensional data analysis Cardiovascular health applications using statistical modeling Recent publications (2022-2025) demonstrate strong emphasis on: Novel statistical methods for medical/biological data Machine learning applications in diagnostics and genomics Clinical risk modeling and epidemiological studies Big data reduction techniques and computational efficiency He frequently publishes in interdisciplinary collaborations at the intersection of statistics, biomedicine, and computational science. Awards: Fulbright Scholar He collaborates extensively with the Cardiovascular Institute, contributing statistical expertise to research on cardiovascular outcomes, disease risk modeling, and clinical data analysis.

Jacquin C. Nilesمشاهده پروفایل

دانشیار

• Malaria
• Infectious Disease
• Plasmodium falciparum
• +۷ مورد دیگر

Jacquin C. Niles is the Whitaker Professor in Biomedical Engineering at the Massachusetts Institute of Technology, where he holds a joint appointment in the Department of Biological Engineering. He serves as Director of the MIT Center for Environmental Health Sciences and is an Associate Member of the Broad Institute. As an HHMI-Gates Faculty Scholar, Dr. Niles leads a research program focused on developing molecular tools to combat infectious diseases, particularly malaria. Education: B.S. in Chemistry, Massachusetts Institute of Technology M.D., Harvard Medical School Ph.D. in Molecular Toxicology, Massachusetts Institute of Technology Postdoctoral training, Department of Chemistry, UC Berkeley (Michael Marletta's lab) Dr. Niles' research program centers on developing innovative molecular tools to address critical questions in infectious disease biology, with a specific focus on malaria and Plasmodium falciparum . His lab emphasizes creating a versatile molecular toolkit for controlling gene expression and protein function in malaria parasites, which enables the elucidation of parasite gene function. This work integrates expertise across biomolecular engineering, chemical biology, synthetic biology, analytical chemistry, biochemistry, and molecular and cell biology to develop solutions applicable across various pathogens and model organisms. Analysis of Dr. Niles' recent publications reveals a consistent focus on developing and applying novel molecular technologies to malaria research. His work spans CRISPR-based genome editing, RNA-protein interaction systems for gene regulation, biosensor development for heme and zinc metabolism, and microfluidic approaches for malaria diagnostics. These publications demonstrate a progression from fundamental tool development to increasingly sophisticated applications in parasite biology and host-pathogen interactions. Scientific Awards: HHMI-Gates Faculty Scholar Dr. Niles has mentored numerous graduate students, postdoctoral researchers, and undergraduates through the Niles Laboratory. His former students have gone on to successful careers in academia, industry, and medicine. His research program has been supported by various grants that enable the development of novel molecular approaches to studying and combating malaria. The lab consists of a multidisciplinary team of Biological Engineers, Chemists, and Microbiologists working collaboratively to address challenges in infectious disease research. The Niles Laboratory, located at MIT, serves as a hub for innovative research at the intersection of engineering and infectious disease biology. The lab's collaborative environment fosters the development of new technologies that have applications beyond malaria research, contributing to broader advances in molecular biology and biomedical engineering.

Lin Linمشاهده پروفایل

دانشیار

• Biostatistics
• Bioinformatics
• Statistical Science
• +۷ مورد دیگر

Lin Lin is an Associate Professor of Biostatistics & Bioinformatics at Duke University's Division of Integrative Genomics and an Associate Research Professor of Statistical Science in Trinity College of Arts & Sciences. With appointments dating from 2022 to present, Dr. Lin has established herself as a prominent researcher at the intersection of statistics, bioinformatics, and biomedical applications. Her work spans multiple departments and research centers at Duke, reflecting her interdisciplinary approach to solving complex biological problems. Ph.D. from Duke University (2012) Dr. Lin's research focuses on developing advanced statistical and machine learning methods for analyzing complex biological data, particularly in immunology and transplantation research. Her expertise in single-cell data analysis, cytometry data interpretation, and biomarker discovery has led to significant contributions in vaccine studies, HIV/AIDS research, and organ transplantation. She has pioneered methods for handling small cohort studies, longitudinal data, and multi-modal datasets, addressing critical challenges in modern biomedical research where traditional statistical approaches fall short. Analysis of Dr. Lin's publication record reveals a strong emphasis on developing interpretable computational methods that bridge the gap between complex data and biological insights. Her recent work shows increasing sophistication in handling high-dimensional single-cell data, with a particular focus on creating models that maintain interpretability while achieving high predictive accuracy. The trajectory of her research demonstrates a consistent pattern of addressing methodological challenges in biomedical data analysis, with applications spanning immunology, transplantation medicine, and infectious disease research. Dr. Lin has secured substantial research funding from multiple prestigious sources including the National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Heart, Lung, and Blood Institute, and National Institute of Environmental Health Sciences. Her grants portfolio demonstrates expertise across diverse biomedical domains, from HIV/AIDS research to transplantation immunology and environmental health effects. These projects typically involve developing novel statistical methodologies while addressing pressing clinical questions, showcasing her ability to bridge theoretical statistics with practical biomedical applications. As an educator, Dr. Lin teaches advanced courses in Bayesian statistical modeling and analysis, contributing to the training of the next generation of biostatisticians and data scientists. Her research group likely focuses on developing computational tools that address real-world challenges in biomedical data analysis, with particular emphasis on making complex models interpretable and applicable to clinical settings.

Janine Reichenbachمشاهده پروفایل

استاد

• Somatic Gene Therapy
• Primary Immunodeficiencies
• Hematopoietic Stem Cell Research
• +۴ مورد دیگر

Prof. Dr. med. Janine Reichenbach is a full professor and head of the Somatic Gene Therapy department at the University of Zurich, affiliated with the University Children's Hospital Zurich. She holds dual board certifications in Pediatrics and Adolescent Medicine (Germany/Switzerland) and Allergology & Clinical Immunology (Switzerland). Her career spans over two decades of translational research bridging basic science and clinical implementation of gene therapies. Education: MD from Goethe University Frankfurt (1995-1997), medical training in Germany (1997-2000), and specialist certifications in Switzerland (2005-2009). Research Focus: Translational development of hematopoietic stem cell-based gene therapies for primary immunodeficiencies, particularly chronic granulomatous disease (CGD) and ataxia telangiectasia (A-T). Key projects include lentiviral vector design, genome editing at ATM locus, and myeloid-targeted therapies with brain-crossing potential. Awards: Recipient of the 2010 Walther und Gertrud Siegenthaler Stiftung prize. Grants: Leads Swiss National Science Foundation projects, University Research Priority Programs (URPP Itinerare), Clinical Research Priority Programs (CRPP ImmuGene), and Wyss Centre collaborations. Leadership: Principal investigator in EU-FP7 projects CELL-PID and NET4CGD, steering committee member for SCID newborn screening, and co-founder of international research networks.

Sabine A. Fuchsمشاهده پروفایل

استاد

• Metabolic Diseases
• Genetic Diseases
• Pediatrics
• +۵ مورد دیگر

Sabine A. Fuchs is a Full Professor and pediatrician specializing in metabolic diseases at Utrecht University Medical Center (UMC-Utrecht), holding a Principal Investigator position at the Hubrecht Institute's Regenerative Medicine and Stem Cell Research group (RMCU). Her dual clinical-research role bridges patient care with translational science in pediatric genetic disorders. Her academic journey includes cum laude degrees in Pharmacy and Medicine from Utrecht University, supplemented by research in Edinburgh (Prof. Webb) and clinical training at Harvard Medical School. She completed pediatric specialization alongside a ZonMW AGIKO-funded PhD in metabolic diseases, later establishing her independent research line through a ZonMW Klinische Fellows grant. Dr. Fuchs' research centers on metabolic and genetic diseases in children, with emphasis on mitochondrial disorders and inborn errors of metabolism. She pioneers mRNA-based therapeutics, in vivo gene correction, and mitochondrial function restoration, developing innovative platforms like liver organoids for disease modeling. Her work integrates clinical insights with molecular diagnostics to address unmet therapeutic needs. Recent publications reveal strong trends in mRNA delivery systems for genetic diseases, aminoacyl-tRNA synthetase deficiency treatments, and advanced cellular screening for variant interpretation. Her group's work on mitochondrial phenotyping and amino acid metabolism demonstrates a multidisciplinary approach spanning nanomedicine, stem cell biology, and metabolic engineering. Her 2024 awards include: €200,000 Biotech Booster grant for HeLLO €150,000 ERC Proof of Concept grant for IMPACT €1.5 million ZonMW VICI grant for in vivo gene correction €15,000 Tjallingh Roorda Stichting grant for mitochondrial disease therapies Dr. Fuchs supervises PhD candidates through grants like the Tjallingh Roorda project and leads collaborative research funded by ZonMW, ERC, and Dutch foundations. Her grants portfolio exceeds €2 million in 2024, supporting translational pipelines from basic discovery to clinical application. She directs a research team within the RMCU at the Hubrecht Institute, collaborating with UMC-Utrecht clinicians and international partners to advance regenerative medicine approaches for childhood metabolic disorders through stem cell models and gene editing technologies.

• Phytochemical Research
• Cancer Therapeutics
• Cardiovascular Pharmacology
• +۵ مورد دیگر

Dr. Matthew Jones is a Lecturer in Physiology at the University of Salford, School of Science, Engineering & Environment, specializing in Biomedicine. He serves as Deputy Programme Leader for the Biomedical Science Programme with emphasis on supporting level 4 students, and acts as Admissions Tutor for the Biomedicine suite of programmes including Biomedical Science, Human Biology and Infectious Diseases. His educational background includes a BSc in Biomedical Science with Professional Experience (2016), MSc by research (2017), and PhD (2021), all completed at the University of Salford. His PhD research investigated the chemical composition and anti-cancer potential of Boswellia carterii oleoresins under Professor David Greensmith. Dr. Jones's research spans two primary domains: phytochemical pharmacology and biomedical education. His pharmacological work focuses on understanding the therapeutic potential of novel phytochemicals for childhood brain cancers, cardiovascular disorders, and inflammatory conditions, with particular expertise in examining cardiotoxic effects at the single-cell level. His educational research investigates student transitions to higher education, awarding gaps, and active learning approaches in Biomedicine. He has developed innovative teaching methods including digital escape rooms and card games to enhance student engagement in laboratory settings. Analysis of his 42 research outputs (primarily from 2023-2025) reveals a strong dual focus: approximately 60% of his work centers on cancer pharmacology (particularly medulloblastoma and leukemia treatments using plant-derived compounds), while 40% addresses educational innovations in biomedical science teaching. His cancer research consistently examines pro-apoptotic and anti-migratory effects of phytochemicals, while his educational work emphasizes gamified and active learning approaches to improve student outcomes. As module leader for Biomedical Skills and Human Physiology, Dr. Jones teaches across all undergraduate levels in courses including Professional Skills, Human Systems Physiology, Translational Research Skills, and Advances in Pathophysiology. He actively supervises undergraduate and Master's research projects and is available for PhD supervision in areas including cardiotoxicity of phytochemicals, anti-cancer effects of novel phytochemicals, and impact of inflammatory dysregulation on cardiac function. His experimental expertise encompasses flow cytometry, various microscopy techniques, cell culture, molecular biology, and analytical chemistry including HPLC and mass spectrometry. Dr. Jones contributes to the UN Sustainable Development Goals focused on 'Ensure healthy lives and promote well-being for all at all ages' and 'Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all,' reflecting his dual commitment to biomedical research and educational excellence.

Enrico Lugliمشاهده پروفایل

پژوهشگر

• Immunology
• Cancer Immunotherapy
• T Cell Biology
• +۳ مورد دیگر

Enrico Lugli serves as Group Leader of the Translational Immunology Lab and Head of the Flow Cytometry core facility at Humanitas University, where he directs cutting-edge research in cancer immunology using single-cell technologies. Education: PhD in Immunology, University of Modena and Reggio Emilia, Italy Postdoctoral training at Vaccine Research Center, National Institutes of Health, USA His research focuses on dissecting T cell responses in cancer through high-dimensional approaches including 30-parameter flow cytometry and single-cell RNA sequencing. Key investigations target stem-like memory T cell differentiation pathways and immunosuppressive mechanisms mediated by regulatory T cells in tumor microenvironments, aiming to overcome resistance to current immunotherapies. Analysis of his publication record (2011-2023) reveals consistent innovation in T cell biology, particularly in characterizing stem-like progenitor subsets and hyperactivated regulatory T cells across multiple cancer types. The work demonstrates a progression from fundamental discoveries of T cell subsets to clinical translation using advanced computational and spatial profiling techniques. Scientific Awards: European Research Council Starting Grant Lloyd J. Old STAR award from Cancer Research Institute Fondazione AIRC grant Italian Ministry of Health grant Dr. Lugli mentors four PhD students and leads a multidisciplinary team including bioinformaticians and postdoctoral fellows. His ERC-funded research program investigates T cell differentiation dynamics and immunosuppressive networks, with recent work identifying hyperactivated Treg subsets as therapeutic targets in cholangiocarcinoma and other solid tumors. The Translational Immunology Lab operates within Humanitas University's research ecosystem, integrating the Flow Cytometry core facility to enable high-parameter immune profiling. Current initiatives include developing computational tools like CRUSTY for flow cytometry data analysis and exploring metabolic pathways that sustain immunosuppressive cell functions.